We are a leading generic pharmaceutical company with a significant presence in the Middle East and North Africa (”MENA”) region, the United States and Europe.
Currently, we sell 176 pharmaceutical products in 397 dosage strengths and forms in 40 countries. 28 of our products are sold under promotion and distribution agreements with, or licenses from, 16 originator pharmaceutical companies and three generic pharmaceutical companies.